SEARCH

SEARCH BY CITATION

References

  • 1
    Conner JM, Lauterborn JC, Yan Q, Gall CM, Varon S. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci 1997; 17: 22952313.
  • 2
    Yan Q, Rosenfeld RD, Matheson CR, et al. Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system. Neuroscience 1997; 78: 431448.
  • 3
    Scharfman HE. Brain-derived neurotrophic factor and epilepsy – a missing link? Epilepsy Curr 2005; 5: 8388.
  • 4
    Binder DK, Scharfman HE. Brain-derived neurotrophic factor. Growth Factors 2004; 22: 123131.
  • 5
    Binder DK. The role of BDNF in epilepsy and other diseases of the mature nervous system. Adv Exp Med Biol 2004; 548: 3456.
  • 6
    Gall CM. Seizure-induced changes in neurotrophin expression: implications for epilepsy. Exp Neurol 1993; 124: 150166.
  • 7
    Elmer E, Kokaia Z, Kokaia M, Carnahan J, Nawa H, Lindvall O. Dynamic changes of brain-derived neurotrophic factor protein levels in the rat forebrain after single and recurring kindling-induced seizures. Neuroscience 1998; 83: 351362.
  • 8
    Murray KD, Isackson PJ, Eskin TA, et al. Altered mRNA expression for brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase in the hippocampus of patients with intractable temporal lobe epilepsy. J Comp Neurol 2000; 418: 411422.
  • 9
    Scharfman HE, Goodman JH, Sollas AL. Actions of brain-derived neurotrophic factor in slices from rats with spontaneous seizures and mossy fiber sprouting in the dentate gyrus. J Neurosci 1999; 19: 56195631.
  • 10
    Zhu WJ, Roper SN. Brain-derived neurotrophic factor enhances fast excitatory synaptic transmission in human epileptic dentate gyrus. Ann Neurol 2001; 50: 188194.
  • 11
    Kokaia M, Ernfors P, Kokaia Z, Elmer E, Jaenisch R, Lindvall O. Suppressed epileptogenesis in BDNF mutant mice. Exp Neurol 1995; 133: 215224.
  • 12
    LaFrance WC Jr, Leaver K, Stopa EG, Papandonatos GD, Blum AS. Decreased serum BDNF levels in patients with epileptic and psychogenic nonepileptic seizures. Neurology 2010; 75: 12851291.
  • 13
    Vignali DA. Multiplexed particle-based flow cytometric assays. J Immunol Methods 2000; 243: 243255.
  • 14
    Dupont NC, Wang K, Wadhwa PD, Culhane JF, Nelson EL. Validation and comparison of Luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants. J Reprod Immunol 2005; 66: 175191.
  • 15
    Hong Z, Shi M, Chung KA, et al. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain 2010; 133: 713726.
  • 16
    Blume WT, Luders HO, Mizrahi E, Tassinari C, van Emde Boas W, Engel J Jr. Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia 2001; 42: 12121218.
  • 17
    Erickson KI, Prakash RS, Voss MW, et al. Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume. J Neurosci 2010; 30: 53685375.
  • 18
    Ziegenhorn AA, Schulte-Herbruggen O, Danker-Hopfe H, et al. Serum neurotrophins – a study on the time course and influencing factors in a large old age sample. Neurobiol Aging 2007; 28: 14361445.
  • 19
    Yasutake C, Kuroda K, Yanagawa T, Okamura T, Yoneda H. Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer's disease and vascular dementia. Eur Arch Psychiatry Clin Neurosci 2006; 256: 402406.
  • 20
    Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 2008; 64: 527532.
  • 21
    Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002; 109: 143148.
  • 22
    Lommatzsch M, Zingler D, Schuhbaeck K, et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 2005; 26: 115123.
  • 23
    Angelucci F, Spalletta G, di Iulio F, et al. Alzheimer's disease (AD) and mild cognitive impairment (MCI) patients are characterized by increased BDNF serum levels. Curr Alzheimer Res 2010; 7: 1520.
  • 24
    Forlenza OV, Diniz BS, Teixeira AL, et al. Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment. World J Biol Psychiatry 2010; 11: 774780.
  • 25
    Waragai M, Wei J, Fujita M, et al. Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease. Biochem Biophys Res Commun 2006; 345: 967972.
  • 26
    Nakahashi T, Fujimura H, Altar CA, et al. Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett 2000; 470: 113117.
  • 27
    Lorgis L, Amoureux S, de Maistre E, et al. Serum brain-derived neurotrophic factor and platelet activation evaluated by soluble P-selectin and soluble CD-40-ligand in patients with acute myocardial infarction. Fundam Clin Pharmacol 2010; 24: 525530.
  • 28
    Yamamoto H, Gurney ME. Human platelets contain brain-derived neurotrophic factor. J Neurosci 1990; 10: 34693478.